EPA AND HEPATIC SYNTHESIS AND SECRETION OF THE VLDL
EPA 与肝脏 VLDL 的合成和分泌
基本信息
- 批准号:3355924
- 负责人:
- 金额:$ 11.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-07-01 至 1990-06-30
- 项目状态:已结题
- 来源:
- 关键词:HMG coA reductases antihyperlipoproteinemic agent antiserum apolipoproteins blood lipid blood lipoprotein biosynthesis cholesterol density gradient ultracentrifugation diet therapy dietary lipid electrofocusing enzyme mechanism esterification fatty acid metabolism gas chromatography gel electrophoresis immunoprecipitation ketones laboratory rabbit laboratory rat lipid biosynthesis liver cells liver metabolism microsomes nutrition related tag oleate omega 3 fatty acid oxidation palmitates perfusion radioimmunoassay radiotracer saturated fatty acids scintillation spectrometry steroid biosynthesis thin layer chromatography triglycerides vegetable oils very low density lipoprotein
项目摘要
We propose to investigate the mechanisms by which
eicosopentaenoic acid (EPA) and docosohexaenoic acid (DHA) act
to reduce plasma concentrations of triglyceride (TG) and
cholesterol (C). Our approach to the problem will be to study the
hepatic metabolism of fatty acids, the formation and secretion of
the very low density lipoprotein (VLDL), its relationship to
cholesterogenesis, and the effects of omega-3-polyunsaturated
fatty acids on these processes. Experiments will be carried out in
model systems in vitro using the rat as an experimental animal,
but will be correlated with complementary in vivo studies. Using
isolated perfused livers obtained from normal chow fed rats, we
will evaluate the uptake of EPA and DHA, the output of TG, and
rates of oxidation, compared to other fatty acids. The total
disposition of (U-14C)EPA and DHA among metabolic pathways
will be determined. The possibility that EPA and DHA might
alter the hepatic metabolism of the common mammalian fatty
acids will be investigated. The effects of EPA/DHA on output of
VLDL lipids, the lipid and apoprotein composition of the VLDL,
the synthesis and secretion of VLDL apoproteins, and the
characterization of the VLDL in the zonal ultracentrifuge will be
studied in detail under conditions described above. Since fatty
acids stimulate hepatic secretion and denovo synthesis of C, the
effects of EPA and DHA on these parameters will be investigated.
Furthermore, the effects of EPA/DHA on the coordinate
stimulation by fatty acids of enzymes of cholesterogenesis (HMG-
CoA reductase, HMG-CoA synthase, AcAc CoA thiolase) will be
investigated, as will any intrinsic activity of the omega-3-fatty
acids. These parameters will also be evaluated in livers obtained
from animals on diets high in EPA, compared with diets
supplemented with lard or olive oil. Furthermore, we will
correlate these dietary studies with estimation of hepatic
secretion of VLDL in vivo. As adjuncts to our primary studies
with the perfused liver, we will evaluate fatty acid metabolism,
with emphasis on synthesis of triglyceride, by isolated
hepatocytes and microsomal preparations. These comparative
experiments will help us evaluate the efficacy of EPA/DHA as
substrates for TG synthesis, as well as putative competitive
inhibitors of other common fatty acid substrates. The
extraordinary effects of omega-3-unsaturated fatty acids to lower
plasma TG and C, the obvious clinical relevance of these
observations, and the probability that they act through regulation
of VLDL synthesis and secretion form the basis of this proposal.
我们建议调查其机制
二十碳五烯酸 (EPA) 和二十二碳六烯酸 (DHA) 作用
降低血浆甘油三酯 (TG) 浓度和
胆固醇(C)。 我们解决这个问题的方法是研究
脂肪酸的肝脏代谢、脂肪酸的形成和分泌
极低密度脂蛋白(VLDL),其与
胆固醇生成和 omega-3-多不饱和脂肪酸的影响
脂肪酸对这些过程的影响。 实验将在
使用大鼠作为实验动物进行体外模型系统,
但将与补充体内研究相关。 使用
从正常饲料喂养的大鼠中获得分离的灌注肝脏,我们
将评估 EPA 和 DHA 的吸收、TG 的输出以及
与其他脂肪酸相比,氧化速率。 总计
(U-14C)EPA 和 DHA 在代谢途径中的分布
将被确定。 EPA 和 DHA 可能
改变常见哺乳动物脂肪的肝脏代谢
酸将被研究。 EPA/DHA 对产量的影响
VLDL脂质,VLDL的脂质和脱辅基蛋白组成,
VLDL 脱辅基蛋白的合成和分泌,以及
区带超速离心机中 VLDL 的表征将是
在上述条件下进行了详细研究。 既然胖了
酸刺激肝脏分泌和C的重新合成,
将研究 EPA 和 DHA 对这些参数的影响。
此外,EPA/DHA 对协调的影响
脂肪酸刺激胆固醇生成酶(HMG-
CoA 还原酶、HMG-CoA 合酶、AcAc CoA 硫解酶)
研究了 omega-3-脂肪的任何内在活性
酸。 这些参数也将在获得的肝脏中进行评估
与饮食相比,来自饮食中富含 EPA 的动物
补充猪油或橄榄油。 此外,我们将
将这些饮食研究与肝脏的估计相关联
体内VLDL的分泌。 作为我们初级研究的辅助手段
通过灌注的肝脏,我们将评估脂肪酸代谢,
重点是通过分离来合成甘油三酯
肝细胞和微粒体制剂。 这些比较
实验将帮助我们评估 EPA/DHA 的功效
TG 合成的底物,以及假定的竞争性底物
其他常见脂肪酸底物的抑制剂。 这
omega-3 不饱和脂肪酸对降低
血浆 TG 和 C,这些明显的临床相关性
观察结果,以及它们通过监管采取行动的概率
VLDL 合成和分泌的研究构成了该提案的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MURRAY HEIMBERG其他文献
MURRAY HEIMBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MURRAY HEIMBERG', 18)}}的其他基金
LIPID/LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质/脂蛋白代谢与心血管疾病
- 批准号:
2212661 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质脂蛋白代谢与心血管疾病
- 批准号:
3541543 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质脂蛋白代谢与心血管疾病
- 批准号:
3541542 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID/LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质/脂蛋白代谢与心血管疾病
- 批准号:
2212659 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID/LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质/脂蛋白代谢与心血管疾病
- 批准号:
2212662 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质脂蛋白代谢与心血管疾病
- 批准号:
3541544 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质脂蛋白代谢与心血管疾病
- 批准号:
3541541 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID/LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质/脂蛋白代谢与心血管疾病
- 批准号:
2027371 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质脂蛋白代谢与心血管疾病
- 批准号:
3541545 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:
LIPID/LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASE
脂质/脂蛋白代谢与心血管疾病
- 批准号:
2212660 - 财政年份:1988
- 资助金额:
$ 11.08万 - 项目类别:














{{item.name}}会员




